1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

New management

Discussion in 'Dendreon' started by anonymous, Aug 22, 2017 at 6:39 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Any news about new management?
     
  2. anonymous

    anonymous Guest

    Hope they clean up the house. Any old Dendreon employee is not good. Anyone who has been here longer than 2 years is not good. If longer than 5, forget it, you are dealing with the worse. Don't bring back old employees. Stop doing that. Do you smell spoiled milk and put it back in the fridge?
     
  3. anonymous

    anonymous Guest

    Hope they clean up the house. Any old Dendreon employee is not good. Anyone who has been here longer than 2 years is not good. If longer than 5, forget it, you are dealing with the worse. Don't bring back old employees. Stop doing that. Do you smell cartoon of spoiled milk and put it back in the fridge?